Evaluating AE Reporting of Two Off-Patent Biologics to Inform Future Biosimilar Naming and Reporting Practices Stella StergiopoulosKenneth Getz Current Opinion 25 June 2015 Pages: 687 - 692
Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit Rashmi R. ShahJoel Morganroth Review Article 26 May 2015 Pages: 693 - 710
Hepatotoxicity of New Oral Anticoagulants (NOACs) Evangelia LiakoniAlexandra E. Rätz BravoStephan Krähenbühl Review Article 03 July 2015 Pages: 711 - 720
Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey Katherine HarrisRebecca DickinsonPeter Knapp Short Communication 23 June 2015 Pages: 721 - 727
Accidents and Incidents Related to Intravenous Drug Administration: A Pre–Post Study Following Implementation of Smart Pumps in a Teaching Hospital Aurélie GuérinJulien TourelJean-François Bussières Short Communication 25 June 2015 Pages: 729 - 736
Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry Linda de JongeHermien E. K. de WalleMarian K. Bakker Original Research Article Open access 04 June 2015 Pages: 737 - 747
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance Yihua XuXiaofeng ZhouAndrew Bate Original Research Article 09 June 2015 Pages: 749 - 765
Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance Yihua XuXiaofeng ZhouAndrew Bate Erratum 02 July 2015 Pages: 767 - 768
